AI Article Synopsis

  • The study examined the expression patterns of tissue markers SATB1 and PTEN in relation to various kidney diseases using 32 biopsy samples, including both proliferative and non-proliferative groups.
  • Both markers were found in all kidney structures, showing particularly high expression in tubular epithelial cells and significant differences in expression levels when compared to healthy control samples.
  • The findings suggest SATB1 and PTEN could serve as potential indicators of kidney disease progression and warrant further investigation for their role in kidney disease treatment.

Article Abstract

Background: In present study we investigated expression pattern of the special tissue markers. SATB1 and PTEN to evaluate possible influence in pathophysiology and development of various biopsy proven kidney diseases.

Methods: The 32 kidney biopsy samples were analysed using light, immunofluorescence and electron microscopy. There were 19 samples in proliferative and 13 samples in non- proliferative group of renal diseases. As control group, 9 specimens of healthy kidney tissue taken after surgery of kidney tumour were used. SATB1 and PTEN markers were used for immunofluorescence staining. Analysed tissue structures were glomeruli, proximal convoluted tubules (PCT) and distal convoluted tubules (DCT). The number of SATB1 and PTEN cells were calculated and the data compared between kidney structures, disease groups and control specimens.

Results: Both markers were positive in all investigated kidney structures, with expression generally, more prominent in tubular epithelial cells than in glomeruli, with the highest staining intensity rate as well as highest rate of both markers in DCT of proliferative diseases group (SATB1 64.5 %, PTEN 52 %). There was statistically significant difference in SATB1 expression in all tissue structures of interest in proliferative as well as non- proliferative group compared to control group (p < 0.01-p < 0.0001). PTEN expression were found significantly decreased in PCT of both disease groups in regard to control (PTEN 25.3 % and 23.8 % vs. 41.1 % (p < 0.01 and p < 0.001 respectively).

Conclusion: SATB1 and PTEN could be considered as markers influenced in kidney disease development. SATB1/PTEN expression should be further investigated as useful markers of kidney disease activity as well as potential therapeutic target.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acthis.2020.151631DOI Listing

Publication Analysis

Top Keywords

satb1 pten
16
biopsy proven
8
proven kidney
8
non- proliferative
8
proliferative group
8
control group
8
tissue structures
8
convoluted tubules
8
kidney structures
8
kidney
7

Similar Publications

Article Synopsis
  • The study examined the expression patterns of tissue markers SATB1 and PTEN in relation to various kidney diseases using 32 biopsy samples, including both proliferative and non-proliferative groups.
  • Both markers were found in all kidney structures, showing particularly high expression in tubular epithelial cells and significant differences in expression levels when compared to healthy control samples.
  • The findings suggest SATB1 and PTEN could serve as potential indicators of kidney disease progression and warrant further investigation for their role in kidney disease treatment.
View Article and Find Full Text PDF

Numerous efforts have been made for developing text-mining tools to extract information from biomedical text automatically. They have assisted in many biological tasks, such as database curation and hypothesis generation. Text-mining tools are usually different from each other in terms of programming language, system dependency and input/output format.

View Article and Find Full Text PDF

Background: Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM). We studied the expression of special AT-rich sequence binding protein 1 (SATB1) and phosphatase and tensin homologue (PTEN) in the kidneys of diabetic rats during ageing.

Methods: Male Sprague Dawley rats were injected with 55 mg/kg streptozotocin (STZ) (DM group) or with citrate buffer (control group).

View Article and Find Full Text PDF

Loss of the BRCA1-interacting helicase BRIP1 results in abnormal mammary acinar morphogenesis.

PLoS One

June 2014

Radiobiology for Children's Health Program, Research Center for Radiation Protection, National Institute of Radiological Sciences, Chiba, Japan ; Radiation Effect Accumulation and Prevention Project, Fukushima Project Headquarters, National Institute of Radiological Sciences, Chiba, Japan.

BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer susceptibility protein BRCA1 and plays an important role in BRCA1-dependent DNA repair and DNA damage-induced checkpoint control. Recent studies implicate BRIP1 as a moderate/low-penetrance breast cancer susceptibility gene. However, the phenotypic effects of BRIP1 dysfunction and its role in breast cancer tumorigenesis remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!